ticker
Login
business news
Politics And Regulation
Markets
The Economy
Editor's Pick
trading and investing
Stocks
ETFs
Fixed Income
Earnings
Currencies
Commodities
Options
Taxes
Personal Finance
How To Trade
How To Invest
sectors
Biotech/pharma
Consumer
Energy
Financial
Global Markets
Media
Precious Metals
Real Estate
Technology
Transportation
special features
Wall Of Worry
Random Thoughts
Sports Business
Minyanville Press
Video
Hoofy & Boo
Radio
MV PREMIUM
subscriptions
Launch Buzz And Banter
Buzz And Banter
Elliott Wave Insider
Tchir's Fixed Income Report
Cooper's Market Report
Techstrat Report
Optionsmith
The Stock Playbook
Ad Free Minyanville
Minyanville Book Store
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
GlaxoSmithKline PLC ADS
(NY:
GSK
)
52.47
USD
-0.27 (-0.51%)
Official Closing Price
/ Updated:
6:40 PM EDT, Jun 18, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
1,352,247
Open
52.37
Bid (Size)
52.47 (300)
Ask (Size)
52.48 (400)
Prev. Close
52.74
Today's Range
52.19 - 52.57
52wk Range
41.68 - 54.00
Shares Outstanding
2,459,950,090
Dividend Yield
3.97%
Featured News
More News
Oil firms boost FTSE 100 after upgrade
June 17, 2013
Oil firms lead U.K. stocks higher after a broker upgrade on Monday, while shares of GlaxoSmithKline PLC also show upbeat moves after a target price lift.
Read More
category
UK:ABF
,
HK:5
,
UK:LLOY
, and 28 more.
from
MarketWatch
Avandia win a Pyrrhic victory for consumers
June 14, 2013
The Type 2 diabetes drug Avandia was essentially taken off the market by the FDA for several years because of a study that said it was dangerous. It’s now back, but the lesson learned here may not be...
Read More
category
Opinion
,
Commentary
,
General
, and 5 more.
from
MarketWatch
Featured News
Read More
Stock Upgrades: France Likes What It Sees in Lululemon
June 07, 2013
category
UAL
,
LULU
,
GSK
from
Minyanville Headlines
Banks, oil firms push FTSE 100 lower
May 29, 2013
category
HK:5
,
UK:BARC
,
BP
, and 25 more.
from
MarketWatch
Stock Upgrades: Can Merck Lead the Dow to Another Terrific Tuesday?
May 28, 2013
category
MRK
,
AAPL
,
GSK
, and 1 more.
from
Minyanville Headlines
U.K.’s FTSE 100 rallies, boosted by banks, GSK
May 28, 2013
category
UK:STAN
,
HK:5
,
UK:BARC
, and 21 more.
from
MarketWatch
Europe stocks key off Asia gains; banks rally
May 28, 2013
category
HK:5
,
Retail
,
DX:DAX
, and 25 more.
from
MarketWatch
U.K. stocks decline, shrug off GDP data
April 25, 2013
category
VZ
,
UL
,
UK:ADM
, and 17 more.
from
MarketWatch
More News
Read More
Call for overhaul of drug industry business model
June 18, 2013
from
FOX News
RDInvesting Provides Investors with Free In-Depth Equity Reports on CSIQ, GSK, KSS and LMT
June 18, 2013
from
ACCESSWIRE
GlaxoSmithKline (GSK) Receives Bid for Thrombosis Brands, NDB Site
June 18, 2013
from
StreetInsider.com News Articles
S.Africa's Aspen offers to buy GSK thrombosis drugs
June 18, 2013
category
companyNews
from
Reuters: Company News
Royalty Pharma’s bid for Elan in jeopardy
June 17, 2013
category
Theravance Inc/
,
Rory Riggs
,
Health Care
, and 4 more.
from
Business Journals
UPDATE 1-Royalty hostile bid for Elan in doubt after vote
June 17, 2013
category
companyNews
from
Reuters: Company News
Elan shareholders approve buyback in blow to Royalty bid
June 17, 2013
from
FOX News
Elan shareholders approve buyback in blow to Royalty bid
June 17, 2013
category
companyNews
from
Reuters: Company News
UK scientists win funding for new kind of anticoagulant drug
June 16, 2013
category
companyNews
from
Reuters: Company News
Genome Research Benefits Growing, Getting Cheaper
June 16, 2013
category
tvtech
,
Technology
,
Myriad Genetics Inc
, and 14 more.
from
CNBC.com News
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Stay Connected
WHAT'S POPULAR IN THE VILLE
1
The QE Carry Trade Is Imploding Right Under Everyone's Noses
Vince Foster
2
Immunotherapy: Four Companies on the Verge of Cancer-Treatment Breakthroughs
TM Meyer
3
Why Apple Inc. Can't Be Forgiven for iOS 7
Mike Schuster
4
What Now, Mr. Bernanke? Traders Position Into the FOMC Rate Decision
Todd Harrison
5
In Insider Trading, Phillip Frost Increases Stake in Opko Health Inc. and Larry Page Sells Shares of Google Inc
Jonathan Moreland
See All Articles
»